Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Effects of levetiracetam monotherapy on the cognitive function of epilepsy patients.

Koo DL, Hwang KJ, Kim D, Kim YJ, Kim JY, Shin W, Kim MR, Joo EY, Lee JM, Hong SB.

Eur Neurol. 2013;70(1-2):88-94. doi: 10.1159/000347230. Epub 2013 Jul 2.

PMID:
23839084
2.

Effect of levetiracetam monotherapy on background EEG activity and cognition in drug-naïve epilepsy patients.

Cho JR, Koo DL, Joo EY, Yoon SM, Ju E, Lee J, Kim DY, Hong SB.

Clin Neurophysiol. 2012 May;123(5):883-91. doi: 10.1016/j.clinph.2011.09.012. Epub 2011 Oct 13.

PMID:
22000706
3.

Effect of levetiracetam on cognitive functions and quality of life: a one-year follow-up study.

López-Góngora M, Martínez-Domeño A, García C, Escartín A.

Epileptic Disord. 2008 Dec;10(4):297-305. doi: 10.1684/epd.2008.0227.

PMID:
19017572
4.

Levetiracetam monotherapy--outcomes from an epilepsy clinic.

Stephen LJ, Kelly K, Parker P, Brodie MJ.

Seizure. 2011 Sep;20(7):554-7. doi: 10.1016/j.seizure.2011.04.004. Epub 2011 May 4.

5.

Levetiracetam monotherapy in patients with brain tumor-related epilepsy: seizure control, safety, and quality of life.

Maschio M, Dinapoli L, Sperati F, Pace A, Fabi A, Vidiri A, Muti P.

J Neurooncol. 2011 Aug;104(1):205-14. doi: 10.1007/s11060-010-0460-x. Epub 2010 Nov 25.

PMID:
21107994
6.

[Follow-up study on levetiracetam monotherapy in children with epilepsy].

Gao ZJ, Jiang YW.

Zhongguo Dang Dai Er Ke Za Zhi. 2008 Dec;10(6):711-4. Chinese.

PMID:
19102836
7.

Cognitive outcome of antiepileptic treatment with levetiracetam versus carbamazepine monotherapy: a non-interventional surveillance trial.

Helmstaedter C, Witt JA.

Epilepsy Behav. 2010 May;18(1-2):74-80. doi: 10.1016/j.yebeh.2010.02.011. Epub 2010 May 13.

PMID:
20462801
8.

Levetiracetam: an improvement of attention and of oral fluency in patients with partial epilepsy.

Piazzini A, Chifari R, Canevini MP, Turner K, Fontana SP, Canger R.

Epilepsy Res. 2006 Mar;68(3):181-8. Epub 2005 Dec 5.

PMID:
16332430
9.

Effects of levetiracetam as a monotherapy on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy.

Koo DL, Joo EY, Kim D, Hong SB.

Epilepsy Res. 2013 Mar;104(1-2):134-9. doi: 10.1016/j.eplepsyres.2012.09.002. Epub 2012 Sep 30.

PMID:
23032070
10.

The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy--an open-label, prospective, randomised controlled multicenter study.

Rosenow F, Schade-Brittinger C, Burchardi N, Bauer S, Klein KM, Weber Y, Lerche H, Evers S, Kovac S, Hallmeyer-Elgner S, Winkler G, Springub J, Niedhammer M, Roth E, Eisensehr I, Berrouschot J, Arnold S, Schröder M, Beige A, Oertel WH, Strzelczyk A, Haag A, Reif PS, Hamer HM; LaLiMo Study Group.

J Neurol Neurosurg Psychiatry. 2012 Nov;83(11):1093-8. doi: 10.1136/jnnp-2011-301999. Epub 2012 May 17.

PMID:
22595362
11.

[Efficacy and safety of levetiracetam (keppra) add-on treatment in adult patients with refractory epilepsy in two tertiary centers].

Auriel E, Chistik V, Blatt I, Margolin N, Neufeld M.

Harefuah. 2007 Apr;146(4):269-71, 318. Hebrew.

PMID:
17476932
12.

Clinical efficacy and cognitive and neuropsychological effects of levetiracetam in epilepsy: an open-label multicenter study.

Wu T, Chen CC, Chen TC, Tseng YF, Chiang CB, Hung CC, Liou HH.

Epilepsy Behav. 2009 Nov;16(3):468-74. doi: 10.1016/j.yebeh.2009.08.026. Epub 2009 Sep 26.

PMID:
19783219
13.

The influence of antiepileptic drugs on cognition: a comparison of levetiracetam with topiramate.

Gomer B, Wagner K, Frings L, Saar J, Carius A, Härle M, Steinhoff BJ, Schulze-Bonhage A.

Epilepsy Behav. 2007 May;10(3):486-94. Epub 2007 Apr 3.

PMID:
17409025
14.

Levetiracetam monotherapy for elderly patients with epilepsy.

Alsaadi TM, Koopmans S, Apperson M, Farias S.

Seizure. 2004 Jan;13(1):58-60.

15.

The effects of levetiracetam on cognition: a non-interventional surveillance study.

Helmstaedter C, Witt JA.

Epilepsy Behav. 2008 Nov;13(4):642-9. doi: 10.1016/j.yebeh.2008.07.012. Epub 2008 Sep 10.

PMID:
18707022
16.

Long-term use of Levetiracetam in patients with severe childhood-onset epilepsy.

von Stuelpnagel C, Holthausen H, Kluger G.

Eur J Paediatr Neurol. 2007 Nov;11(6):341-5. Epub 2007 Apr 17.

PMID:
17442601
17.

[Levetiracetam in the treatment of epilepsy in adults. Experience with monotherapy].

Molins A, Villanueva VE.

Rev Neurol. 2007 Sep 16-30;45(6):331-3. Spanish.

18.

Positive and negative psychotropic effects of levetiracetam.

Helmstaedter C, Fritz NE, Kockelmann E, Kosanetzky N, Elger CE.

Epilepsy Behav. 2008 Oct;13(3):535-41. doi: 10.1016/j.yebeh.2008.05.012. Epub 2008 Jun 25.

PMID:
18583196
19.

KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.

Trinka E, Marson AG, Van Paesschen W, Kälviäinen R, Marovac J, Duncan B, Buyle S, Hallström Y, Hon P, Muscas GC, Newton M, Meencke HJ, Smith PE, Pohlmann-Eden B; KOMET Study Group.

J Neurol Neurosurg Psychiatry. 2013 Oct;84(10):1138-47. doi: 10.1136/jnnp-2011-300376. Epub 2012 Aug 29.

PMID:
22933814
20.

Cognitive effects of a new pyrrolidine derivative (levetiracetam) in patients with epilepsy.

Neyens LG, Alpherts WC, Aldenkamp AP.

Prog Neuropsychopharmacol Biol Psychiatry. 1995 May;19(3):411-9.

PMID:
7624492
Items per page

Supplemental Content

Write to the Help Desk